Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sukyung Woo

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Plos One|April 11, 2018
Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2Ankur Sharma, Doris Mangiaracina Benbrook, Sukyung Woo
Journal of Pharmacokinetics and Pharmacodynamics|March 28, 2006
Pharmacodynamic models for agents that alter production of natural cells with various distributions of lifespansWojciech Krzyzanski, Sukyung Woo, William J Jusko
International Journal of Pharmaceutics|February 13, 2026
Mechanistic PBPK/PD modeling of free and nano-liposomal irinotecan reveals formulation-specific determinants of disposition and efficacyYegwon An, Min H Kang, Sukyung Woo
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2006
Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in ratsSukyung Woo, Wojciech Krzyzanski, William J Jusko
Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2007
Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO)Sukyung Woo, Wojciech Krzyzanski, William J Jusko
Journal of Pharmacokinetics and Pharmacodynamics|August 22, 2009
Methods of utilizing baseline values for indirect response modelsSukyung Woo, Dipti Pawaskar, William J Jusko
Drug Metabolism and Pharmacokinetics|March 3, 2009
Scaling pharmacodynamics from in vitro and preclinical animal studies to humansDonald E Mager, Sukyung Woo, William J Jusko
Journal of Clinical Medicine|December 19, 2019
Development of Prodrugs for PDT-Based Combination Therapy Using a Singlet-Oxygen-Sensitive Linker and Quantitative Systems PharmacologyLuong Nguyen, Mengjie Li, Sukyung Woo, et al.
Journal of Clinical Pharmacology|May 26, 2010
Population pharmacokinetics and pharmacodynamics of brief etomidate infusion in healthy volunteersKotaro Kaneda, Susumu Yamashita, Sukyung Woo, et al.
Journal of Pharmaceutical Technology & Drug Research|May 1, 2018
Bioanalytical method development and validation of HPLCUV assay for the quantification of SHetA2 in mouse and human plasma: Application to pharmacokinetics studyAnkur Sharma, Elangovan Thavathiru, Doris Mangiaracina Benbrook, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Plos One|April 11, 2018
Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2Ankur Sharma, Doris Mangiaracina Benbrook, Sukyung Woo
Journal of Pharmacokinetics and Pharmacodynamics|March 28, 2006
Pharmacodynamic models for agents that alter production of natural cells with various distributions of lifespansWojciech Krzyzanski, Sukyung Woo, William J Jusko
International Journal of Pharmaceutics|February 13, 2026
Mechanistic PBPK/PD modeling of free and nano-liposomal irinotecan reveals formulation-specific determinants of disposition and efficacyYegwon An, Min H Kang, Sukyung Woo
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2006
Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in ratsSukyung Woo, Wojciech Krzyzanski, William J Jusko
Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2007
Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO)Sukyung Woo, Wojciech Krzyzanski, William J Jusko
Journal of Pharmacokinetics and Pharmacodynamics|August 22, 2009
Methods of utilizing baseline values for indirect response modelsSukyung Woo, Dipti Pawaskar, William J Jusko
Drug Metabolism and Pharmacokinetics|March 3, 2009
Scaling pharmacodynamics from in vitro and preclinical animal studies to humansDonald E Mager, Sukyung Woo, William J Jusko
Journal of Clinical Medicine|December 19, 2019
Development of Prodrugs for PDT-Based Combination Therapy Using a Singlet-Oxygen-Sensitive Linker and Quantitative Systems PharmacologyLuong Nguyen, Mengjie Li, Sukyung Woo, et al.
Journal of Clinical Pharmacology|May 26, 2010
Population pharmacokinetics and pharmacodynamics of brief etomidate infusion in healthy volunteersKotaro Kaneda, Susumu Yamashita, Sukyung Woo, et al.
Journal of Pharmaceutical Technology & Drug Research|May 1, 2018
Bioanalytical method development and validation of HPLCUV assay for the quantification of SHetA2 in mouse and human plasma: Application to pharmacokinetics studyAnkur Sharma, Elangovan Thavathiru, Doris Mangiaracina Benbrook, et al.
Pageof 7